A false emerging narrative suggests ethylene oxide (EtO) sterilization is cheaper, easier, and faster than alternatives and thus preferred. Get the facts on the cost of EtO.
Government & Legislative Affairs
In a RealClearHealth op-ed, AdvaMed president and CEO Scott Whitaker outlines how the recently enacted medical device user fee agreement will help the FDA and medical technology innovators.
The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.
Lucy Fraiser, Ph.D., a board-certified toxicologist, recently responded in a letter to the editor of Modern Healthcare about the publication’s recent coverage of the EPA’s work on ethylene oxide.
Congress overwhelmingly approved the fifth Medical Device User Fee Amendment (MDUFA) agreement, helping to ensure new medical technology receives a more efficient FDA review to reach patients sooner if approved.
AdvaMed will hold a conference call for news media on the upcoming MedTech Conference and legislative/policy issues in front of the industry today.
The Advanced Medical Technology Association (AdvaMed), the world’s largest trade association representing medical device manufacturers, has worked alongside FDA and Congressional leaders to negotiate a final agreement that provides FDA…
CEO and surgeon Dr. Lishan Aklog speaks about the tremendous value of medical technology, the sharp disparities patients face, and the importance of policymaking to ease those disparities.
WASHINGTON, D.C. – Today, the Advanced Medical Technology Association (AdvaMed), the world’s largest trade association representing medical device manufacturers, released the following statement from President and CEO Scott Whitaker in response…